A B S T R A C T Previous studies have indicated that
antiidiotypic antibody can modulate expression of idiotype both in vivo and in vitro. Although the precise mechanisms underlying modulation of idiotype expression by antiidiotype remains unclear, a requirement for intact IgG antiidiotypic antibody has been suggested and T cells appear to play a role in some systems. We have studied peripheral blood mononuclear leukocytes (MNL) from a patient with a B cell lymphoma and a circulating IgMK rheumatoid factor (RF) paraprotein in an effort to delineate mechanisms involved in regulation of idiotype expression by antiidiotypic antibody. 1-10% of MNL from this patient could be cytoplasmically stained with specific F(ab')2 antiidiotypic antibody. MNL from the patient spontaneously synthesized IgM RF in culture that possessed the same idiotype as the circulating IgM RF paraprotein. Production of RF by MNL was suppressed by pretreatment with either intact IgG or the F(ab')2 fragments of antiidiotypic antibody (50% inhibitory concentration was 0.2 and 1.1 gg/culture, respectively).
In contrast, the Fab' fragment of antiidiotypic antibody was not inhibitory (up to 57 ,ug/culture) despite retaining demonstrable antiidiotype activity. Suppression of RF production was not observed over the same concentration range with the IgG or F(ab')2 fractions of a non-cross-reactive antiidiotypic antibody prepared against another monoclonal IgMK RF paraprotein or with IgG or F(ab')2 fractions prepared from
INTRODUCTION
Interactions between idiotype and antiidiotype appear to play a role in regulation of immune responses, as initially suggested by Jerne (1) . These interactions can occur at either a cellular level (2) (3) (4) or by way of humoral pathways, such as reactions of antiidiotypic antibody with cell-surface idiotype (5) (6) (7) (8) . In the latter case, both in vitro and in vivo studies have demonstrated that antiidiotypic antibody is capable of modulating subsequent expression of idiotype. The seemingly paradoxical capacity of antiidiotypic antibody to either induce (9) (10) (11) (12) (13) (14) (15) or suppress (5-8) expression of idiotype is consistent with other observations that interactions between idiotype and antiidiotype are demonstrable in both helper (3) and suppressor (2) regulatory T cell circuits. Despite evidence that antiidiotypic antibody is capable of potently regulating levels of idiotype, mechanisms underlying the effects of antiidiotypic antibody remain unclear. In this regard, previous in vivo (16) and in vitro (17) studies in mice have suggested that an intact Fc portion of antiidiotypic IgG is required for antibody-induced suppression of idiotypic expression.
In this study, we analyzed the effects of rigorously characterized antiidiotypic antibody preparations on in vitro release of idiotype by peripheral blood lymphocytes obtained from a patient with a monoclonal B cell lymphoma. The data indicate that (a) antiidiotypic antibody is capable of directly suppressing human B cell release of idiotype, (b) the bivalent antigenbinding fragment (F[ab'k) of antiidiotypic antibody is sufficient for mediating such suppression, (c) an intact Fc portion of antiidiotypic antibody enhances suppression of idiotype, and (d) antiidiotypic antibody inhibits idiotype expression by suppressing synthesis of idiotype.
METHODS
Patient. The patient (Mil) is a 47-yr-old white female who was diagnosed as having a B cell lymphoma on the basis of lymph-node biopsy. Serum protein electrophoresis and immunoelectrophoresis revealed the concomitant presence of a monoclonal IgMK paraprotein (consistently >4.0 g/dl) possessing rheumatoid factor (RF)' activity as assessed by the latex-fixation test (18) and solid-phase radioimmunoassay (RIA) (19) . During the course of this study, the patient was intermittently treated with prednisone and chlorambucil, but blood was also obtained from the patient in the absence of any therapy and the results were comparable to those obtained on chemotherapy.
Preparation and culture of peripheral blood mononuclear leukocytes (MNL). MNL were prepared by density centrifugation according to the method of B6yum (20 Antiidiotypic antisera. Antiserum to IgMKMil was raised in an albino rabbit by subcutaneous injection of the purified paraprotein (2 mg) emulsified in complete Freund's adjuvant, followed 1 wk later by three sequential injections of 0.5 mg of the protein emulsified in incomplete adjuvant at weekly intervals. The animal was bled one week after the last injection. Rabbit antiserum to IgMKS,°was produced by a similar immunization schedule.
Antisera were rendered specific for idiotypic determinants by absorption with normal humat serum proteins covalently conjugated to CNBr-activated agarose gel (25) . 2-ml aliquots of the antisera were diluted with an equal volume of 0.15 M sodium chloride, 0.02 M sodium phosphate, pH 7.4 (PBS), and passed twice through a 5-ml column of the immunoadsorbent containing -25 mg of covalently bonded protein.
Removal of antibodies to shared determinants of IgM was further insured by passage twice through a 5-ml agarose gel column containing 20 mg of covalently bound monoclonal IgMKDau protein, which does not possess RF activity.
To verify the specificity of the absorbed antisera, the capacity to bind the immunogen and an unrelated monoclonal IgM protein of the same light chain type (IgMKDau) was examined before and after absorption by a two-step directbinding radioassay. All solutions were prepared in PBS containing 0.1% RIA grade BSA. Equal aliquots (0.1 ml) of antiserum dilution, the purified paraprotein IgMKMil or IgMKDaU (100 ng/ml) labeled with 1251 (26) (2,000-10,000 cpm/ng) and 0.05 M dithiothreitol were mixed and reacted at room temperature for 16 h. The dithiotreitol prevented interference due to the interaction of IgG with RF active sites by dissociating the IgM into 7S subunits, but did not prevent their subsequent reaction with anti-IgM or antiidiotypic antibodies. Antibody-bound '251-IgM was separated from free antigen by adsorption to killed Staphylococcus aureus (Pansorbin, Calbiochem-Behring Corp., San Diego, CA) added as a 1% suspension (0.2 ml). After reacting for 1 h, the adsorbent was recovered by centrifugation, washed three times with PBS, and counted in a gamma counter (Biogamma, Beckman Instruments, Inc.).
IgG, F(ab')2, and Fab' antiidiotypic preparations. The
IgG fractions of the absorbed antisera were isolated by precipitation with half-saturated ammonium sulfate followed by gel filtration through Sephacryl S-300 in 0.08 M sodium phosphate buffer, pH 7.5. The resulting preparations yielded single bands of the appropriate mobility by polyacrylamide gel electrophoresis in 0.1 M sodium phosphate buffer, pH 7.0, containing 0.1% sodium dodecyl sulfate (SDS) (27) . The IgG fraction of antiidiotypic antiserum to IgMKMII was further examined by sedimentation-equilibrium analysis in an analytical ultracentrifuge equipped with photoelectric scanner absorption optics (28) . These latter studies confirmed the homogeneity of the preparation and indicated a mol wt of 143,400, assuming a partial specific volume (V) of 0.738 ml/ g (29) .
F(ab')2 fragments of the antiidiotypic antibodies were prepared by digestion of the globulin fraction of absorbed antisera with pepsin in 0.1 M sodium acetate buffer, pH 4.5, at 37°C for 16 h (30). The substrate to enzyme ratio was 100:1 by weight. After neutralizing with Tris base or dialysis into 0.08 M sodium phosphate buffer, pH 7.5, the F(ab')2 fragments were isolated by gel filtration through Sephadex G-200 or Sephacryl S-200 in the pH-7.5 phosphate buffer. The identity and homogeneity of the isolated fragments were verified by polyacrylamide gel electrophoresis in SDS-phosphate buffer. The F(ab')2 fragments of the anti-IgMKM" antibodies were also characterized by sedimentation-equilibrium analysis in the analytical ultracentrifuge. These studies indicated the presence of a single component having a mol wt of 97,400, assuming the V to be equal to that of the unfragmented IgG molecule.
Fab' fragments of antiidiotypic antibodies were prepared by digestion of the globulin fraction of the absorbed antiserum with pepsin in pH-4.5 sodium acetate buffer for 16 h in the presence of 0.01 M cysteine (30) . Digestion was terminated by dialysis into 0.08 M sodium phosphate buffer, pH 7.5, containing 0.01 M iodoacetamide and the Fab' fragments isolated by gel filtration through Sephacryl S-200. Polyacrylamide gel electrophoresis in SDS-phosphate buffer also verified that cleavage had proceeded, to the monomeric Fab' fragment and further demonstrated the absence of other cleavage products. Furthermore, the isolated Fab' fragments of the anti-IgMKMiI antibodies appeared homogeneous by sedimentation-equilibrium ultracentrifugal analysis and demonstrated a mol wt of 46,600, assuming V to be equal to that of the rabbit IgG. Normal rabbit IgG (Sigma Chemical Co.) was further purified by gel filtration through Sephacryl S-300 in 0.08 M sodium phosphate buffer, pH 7.5. F(ab')2 and Fab' fragments of the normal IgG were prepared as described for antibody preparations. Each gave a single band of the expected mobility by polyacrylamide gel electrophoresis in SDS-phosphate buffer and was homogeneous by sedimentation-equilibrium in the ultracentrifuge. Molecular weights of the normal rabbit IgG, F(ab')2, and Fab' preparations calculated from the latter analyses were 143,500, 98,300 and 45,100, respectively.
Anti (31) . After 45 min of incubation, the cells were washed with PBS at 4°C and then incubated with TRITC-labeled goat anti-rabbit F(ab')2 at 4°C for 45 min. After washing, the cells were immediately examined for surface staining. Controls were performed as described above for cytoplasmic staining procedures.
RESULTS
Specificity of antiidiotypic reagents. The mRF paraprotein (IgMKMiI) was isolated from the patient's serum and a rabbit antiidiotypic serum prepared. As a control for subsequent studies, antiidiotypic serum was prepared against another IgMK RF (IgMKSIo) in a similar fashion. The specificity of the two antiidiotypic reagents was initially examined in a direct-binding assay. Results obtained with a representative preparation of the antiserum to IgMKMIl are shown in Fig.  1 . Before absorption, detectable quantities of both 1251-IgMKDau and l2SI-IgMKMiI were bound by the antiserum when diluted 1:1,600 or greater. After absorption, the globulin fraction (reconstituted to the volume of antiserum taken for absorption) failed to react with the 12sI-IgMKDau at the lowest dilution tested (1:100), but continued to react with the l25I-IgMKMiI when diluted 1:1,600. Comparable results were obtained for the antiserum to IgMKSlo before and after absorption. The individual antiidiotypic specificities of the absorbed antibody preparations were further established by a binding-inhibition assay. Antiidiotype directed against IgMKMiI inhibited binding of IgMKMiI to insolubilized human IgG in a dose-response fashion as depicted in Fig. 2 . Insignificant inhibition was observed with antiidiotype directed against IgMKSo (Fig. 2, upper  panel) . In contrast, anti-IgMKSlo exhibited dose-related inhibition of the binding of IgMKSlO to human IgG, whereas anti-IgMKM" was noninhibitory (Fig. 2, aration through the same column resulted in complete absorption of the antiidiotypic activity. Further evidence that the antiidiotypic activity of the F(ab')2 preparation was not related to contaminating IgG was provided by the chromotographic studies shown in Fig.  4 . IgG (Fig. 4 A) and F(ab')2 (Fig. 4 B) preparations were passed through a Sephadex G-100 column and the fractions analyzed for protein (absorbance at 280 nm) and antiidiotypic activity by the binding-inhibition assay. In each case, the antiidiotypic activity eluted as a single peak of the appropriate apparent molecular weight and paralleled the absorbance at 280 nm. In addition, analysis of the Fab' anti-IgMKMIl preparation under the same conditions (Fig. 4 C) idiotypic determinants as the patient's circulating IgM RF paraprotein. In initial experiments, the MNL were cultured either alone or in the presence of varying concentrations of the IgG fraction prepared from antiIgMKMiI, anti-IgMKSo, or normal rabbit serum. As shown in Fig. 5 , only the IgG fraction prepared from the antiserum directed against the patient's circulating IgM paraprotein was inhibitory over the dose range examined (50% inhibitory concentration _ 0.2 Ag/culture). We were concerned that the apparent inhibition of IgM RF release might be related to carry-over of sufficient antiidiotype antibody from the initial prein- cubation to interfere with the activity of IgM RF in the cell supernatants. To assess this possibility, we assayed supernatants for both IgM and IgM RF. Experiments were performed that established that antiidiotypic antibody did not interfere with the IgM RIA for IgMKMiI. As shown in Table I identical treatment of the patient's T cells did not suppress subsequent B cell synthesis of IgM RF when the fractions were co-cultured (Table II, experiment B) .
Antiidiotypic antibody suppresses synthesis of idiotype. The suppression of idiotype expression by antiidiotypic antibody could have resulted from either inhibition of synthesis and/or secretion of idiotype. To distinguish these possibilities, we examined intracellular levels of IgM and IgM RF after treatment of the patient's MNL with F(ab')2 antiidiotypic antibody. As depicted in Table III , decreased extracellular and intracellular IgM and IgM RF was observed after treatment with a suppressive dose of antiidiotypic antibody.
DISCUSSION
In agreement with animal studies (5) (6) (7) (8) , the capacity of antiidiotypic antibody to suppress human idiotype expression has been demonstrated both in vitro (32) (33) (34) and in vivo (35) (Fig. 3) , the IgG fraction was approximately five times more effective than the F(ab')2 preparation in suppressing in vitro IgM RF release by the patient's blood MNL. In view of previous reports that F(ab')2 antiidiotypic antibody was ineffective in inhibiting murine (16, 17) and human (33) idiotype production, we were concerned that the activity of the F(ab')2 preparation was related to contaminating IgG. In view of the capacity of the bivalent F(ab')2 fragment to suppress in vitro release of idiotype, it was of interest to also examine the activity of monovalent Fab' fragments. It was important first to demonstrate that these preparations retained antiidiotypic activity, as in the binding-inhibition assay (Fig. 3) , which established that Fab' was approximately one-third as active as the IgG and F(ab')2 antiidiotype preparations in this regard. Despite demonstrable antiidiotypic activity, Fab' preparations failed to suppress in vitro idiotype release (Fig. 6) . Taken together, our data therefore suggest that cross-linking of cell surface idiotype is sufficient to prevent idiotype release.
We next turned our attention to the cellular requirements for in vitro suppression by antiidiotypic Suppression of Rheumatoid Factor by Antiidiotypic Antibody antibody. This issue has received limited attention in man. Animal studies have indicated that antiidiotypic antibody may modulate idiotype expression either through T cells (2, 36, 37) or directly at the B cell level (38, 39) . Our studies clearly indicate that antiidiotypic antibody is capable of suppressing idiotype expression at the B cell level without a requirement for intermediary T cells (Table II) . These results are in agreement with recent studies of Geha and Communale (40) demonstrating that antiidiotype is capable of specifically inhibiting idiotype expression at the B cell level.
Information concerning the mechanisms by which antiidiotypic antibody suppresses expression of idiotype is limited. In this regard, the recent studies of Bonagura et al. (34) indicating that antiidiotype is capable of suppressing the appearance of idiotype-positive plasma cells in a pokeweed mitogen driven system are of considerable interest. The observation that F(ab')2 antiidiotype suppressed both extracellular and intracellular IgM and IgM RF in our patient suggest that antiidiotype suppresses synthesis, not secretion, of idiotype. Although we cannot completely exclude a lytic effect of the antiidiotypic preparations on idiotype-positive cells, it should be stressed that these studies were all performed in heat-inactivated fetal calf serum, which argues against a role for complement. Moreover, F(ab')2 antiidiotype preparations did not decrease spontaneous uptake of labeled thymidine by the patient's cells (data not presented).
The suppression of idiotype synthesis by antiidiotype antibody observed in our studies may be related to the phenomenon of effector cell blockade initially described by Schrader and Nossal (41) . In these experiments multivalent antigens were observed to inhibit specific antibody secretion by antibody forming cells. More recent in vitro studies suggest that effector cell blockade is not dependent upon Fc receptors and is reversible (42) . The precise mechanisms by which multivalent ligands suppress secretion of antibody is unclear, although the elegant study of Hannestad and Gaudernack (43) has suggested that secreted antibody may be arrested in transit through the cell membrane by surface-bound ligands. Such a mechanism, however, seems unlikely to account completely for the suppression observed in our studies, since 
